Newel Health, a European HealthTech company specialized in certified digital medical devices, has received CE Class IIa certification for Amicomed, its digital therapeutic for hypertension.
Welldoc is powering Lilly’s new digital health platform, designed to support individuals prescribed incretin therapies such as Zepbound® and Mounjaro®.
Over the past decade, the Steering Committee has played a central role in shaping the success of Frontiers Health and the growth of its broader health innovation ecosystem.
Novo Nordisk and Septerna have announced a global collaboration to develop oral small molecule medicines targeting obesity, type 2 diabetes, and other cardiometabolic diseases.
